ISRG cites procedure and cost initiatives amid U.S. headwinds
ISRG says global procedure growth and innovation remain central, with U.S. growth decelerating but offset by new procedures and ASC expansion. International markets stay strong, and a 2027 Extended Use Instruments program targets lower costs and growth.